Meta AnalysisID 2743

重新评估质子泵抑制剂和组胺-2受体拮抗剂在危重患儿中的应用:系统评价和Meta分析

CRD42019130934

The aim of this review is to evaluate the evidence available regarding the administration of stress ulcer prophylaxis using histamine-2 antagonists and/or proton pump inhibitor in pediatric patients aged 7 days to 18 yea

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
2743
Evidence Id
11301
Core Evidence Id
11301
Source Meta Analysis Id
2693
Herb2 Meta Analysis Id
HBMA002693
Crd Id
CRD42019130934
Title
Reassessing the use of proton pump inhibitors and histamine-2 antagonists in critically ill children: a systematic review and meta-analysis
Review Question
The aim of this review is to evaluate the evidence available regarding the administration of stress ulcer prophylaxis using histamine-2 antagonists and/or proton pump inhibitor in pediatric patients aged 7 days to 18 years old, admitted to the ICU for more than 48 hours. The review seeks to investigate the effect of prophylaxis in preventing gastrointestinal hemorrhage; the complications of nosocomial pneumonia (including ventilator-associated pneumonia); the length of ICU stay and all-cause mortality to understand the risks and benefits of such intervention, so as to guide future management of critically ill children.
Study Type Included
We will include randomised controlled trials (RCTs) and observational studies (prospective or retrospective cohort studies) for this review.
Condition Being Studied
Prevention of stress ulcers in pediatric intensive care unit patients. Outcomes include gastrointestinal hemorrhage, nosocomial pneumonia, length of ICU stay and overall all-cause mortality.
Participant
Paediatric population aged 7 days old to 18 years old admitted into the intensive care unit for more than 48 hours. To exclude preterm infants.
Animal
Human Disease Modelled
Intervention
Stress ulcer prophylaxis using histamine-2 receptor antagonists (H2RAs) and/or proton pump inhibitors (PPIs) of any dose, frequency, duration or route of delivery. To exclude articles using these agents as treatment.
Comparator Control
Patients that did not receive stress ulcer prophylaxis in any form or received placebo treatment
Main Outcome
Gastrointestinal hemorrhage is defined as the presence of gross blood in gastric aspirates, as well as documented haematemesis, hematochezia or melena. Nosocomial pneumonia or hospital-acquired pneumonia, is defined as the development of lung parenchymal infection after at least 48 hours of hospitalization.
Outcome Measure
Additional Outcome
Length of ICU stay and all-cause mortality
Study Method
Intervention, Meta-analysis, Systematic review
Keyword
Child; Critical Illness; Histamine; Histamine Antagonists; Histamine H2 Antagonists; Humans; Proton Pump Inhibitors
Contact
Dominic Yao [email protected]
Organisational Affiliation
Duke-NUS Medical School
Funding Source
Singhealth Duke-NUS Academic Clinical Programme
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
Singapore
Review Stage
Review Ongoing
First Submission Date
2019-04-04
Registration Date
2019-05-09
Anticipated Start Date
2018-10-30
Anticipated Completion Date
2019-05-10
Title Cn
重新评估质子泵抑制剂和组胺-2受体拮抗剂在危重患儿中的应用:系统评价和Meta分析
Title En
Reassessing the use of proton pump inhibitors and histamine-2 antagonists in critically ill children: a systematic review and meta-analysis
Bilingual Status
complete